Clinical Trial Update: Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating chemotherapy plus donor natural killer cell infusion for patients with relapsed or persistent leukemia or myelodysplastic syndromes a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Chemotherapy (chemotherapy)
• Donor natural killer cell infusion (donor-derived natural killer cells)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED | Results posted: 2016-02-12